Healthcare / Medical Care FacilitiesUpdated 2026-05-10 22:07 UTC

TLV/DANE stock hub

TLV/DANE has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TLV/DANEis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

2.7B

Tel Aviv Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

TLV/DANE

In the news

Latest news · TLV/DANE

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/E19.4

P25 n/aP50 n/aP75 n/a

ROE28.9

P25 n/aP50 n/aP75 n/a

ROIC23.2

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TLV/DANE market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

237

Groups with data

Currency

ILS

Showing 237 of 237 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Israel
Country code	IL
Employees	4,288
Employees Change	-2%
Employees Change Percent	-0.05
Enterprise value	ILA 2.8B
Exchange	Tel Aviv Stock Exchange
Financial currency	ILS
First seen	2026-05-10
Industry	Medical Care Facilities
Isin	IL0003140139
Last refreshed	2026-05-10
Market cap	ILA 2.7B
Price	ILA 45,800
Price currency	ILA
Rev Per Employee	677,336.99x
Sector	Healthcare
Sic	7361
Symbol	tlv/DANE
Website	https://www.danel-jobs.co.il

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	4.29%
EV Earnings	24.36x
EV/EBIT	14.23x
EV/EBITDA	9.59x
EV/FCF	14.04x
EV/Sales	0.98x
FCF yield	7.44%
P/B ratio	5.29x
P/E ratio	19.39x
P/S ratio	0.94x
PE Ratio10 Y	29.39x
PE Ratio3 Y	67.47x
PE Ratio5 Y	45.7x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	6.89%
EBITDA Margin	8.15%
FCF margin	6.99%
Gross margin	18.31%
Gross Profit	ILA 531.7M
Gross Profit Growth	1.69%
Gross Profit Growth3 Y	4.61%
Gross Profit Growth5 Y	5.33%
Net Income	ILA 117M
Net Income Growth	470.24%
Net Income Growth Quarters	1%
Net Income Growth Years	2%
Net Income Growth3 Y	0.33%
Net Income Growth5 Y	-1.69%
Pretax Margin	6.45%
Profit Margin	4.03%
Profit Per Employee	ILA 27,274
Profitable Years	2
ROA	9.36
Roa5y	9.93
ROCE	24.91
ROE	28.88
Roe5y	22.62
ROIC	23.21
Roic5y	19.76

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	19.86%
Cagr15y	25.01%
Cagr1y	20.64%
Cagr20y	34.47%
Cagr3y	23.51%
Cagr5y	-1.47%
Div CAGR10	6.41%
Div CAGR3	0.89%
Div CAGR5	-0.15%
EPS Growth	465.1
EPS Growth Quarters	1
EPS Growth Years	2
EPS Growth3 Y	-1.69
EPS Growth5 Y	-3.53
FCF Growth	2.99%
FCF Growth3 Y	10.88%
FCF Growth5 Y	-4.12%
OCF Growth	5.72%
OCF Growth10 Y	16.24%
OCF Growth3 Y	4.66%
OCF Growth5 Y	-2.41%
Revenue Growth	5.26x
Revenue Growth Quarters	48x
Revenue Growth Years	18x
Revenue Growth3 Y	7.1x
Revenue Growth5 Y	7.91x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	ILA 2.17
Assets	ILA 1.4B
Cash	ILA 213.4M
Current Assets	ILA 681M
Current Liabilities	ILA 557.1M
Debt	ILA 326.9M
Debt EBITDA	ILA 1.1
Debt Equity	ILA 0.63
Debt FCF	ILA 1.61
Equity	ILA 515.2M
Interest Coverage	10.7
Liabilities	ILA 845.6M
Long Term Assets	ILA 679.8M
Long Term Liabilities	ILA 288.4M
Net Cash	ILA -113.5M
Net Cash By Market Cap	ILA -4.16
Net Debt EBITDA	ILA 0.48
Net Debt Equity	ILA 0.22
Net Debt FCF	ILA 0.56
Tangible Book Value	ILA 336.6M
Tangible Book Value Per Share	ILA 58.23
WACC	4.27

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.22
Net Working Capital	ILA 4.7M
Quick ratio	1.17
Working Capital	ILA 123.8M
Working Capital Turnover	ILA 21.87

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-1.01%
Dividend Growth	128.26%
Dividend Growth Years	2%
Dividend per share	ILA 15.57
Dividend Years	25
Dividend Yield	3.4%
Ex Div Date	2026-03-30
Last Dividend	ILA 3.89
Payout Frequency	Semi-Annual
Payout Ratio	69.04%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	511.98%
1Y total return	20.62%
200-day SMA	47,208.1
3Y total return	88.43%
50-day SMA	45,944.4
50-day SMA vs 200-day SMA	50under200
5Y total return	-7.13%
All Time High	78,900
All Time High Change	-41.95%
All Time High Date	2022-02-10
All Time Low	706
All Time Low Change	6,387.25%
All Time Low Date	2003-04-02
ATR	1,376.1
Beta	0
Beta1y	-0.11
Beta2y	-0.09
Ch YTD	-2.97
High	46,500
High52	54,980
High52 Date	2025-10-21
High52ch	-16.7%
Low	45,290
Low52	37,590
Low52 Date	2025-05-25
Low52ch	21.84%
Ma50ch	-0.31%
Price vs 200-day SMA	-2.98%
RSI	44.75
RSI Monthly	55.93
RSI Weekly	72.66
Sharpe ratio	0.74x
Sortino ratio	1.24
Total Return	2.39%
Tr YTD	-2.11
Tr15y	2,746.35%
Tr1m	-0.43%
Tr1w	-4.38%
Tr3m	-1.76%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	ILA 200.2M
Operating Income Growth	1.4
Operating Income Growth3 Y	3.83
Operating Income Growth5 Y	1.81
Operating margin	6.89

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	4,802,105%
Net Borrowing	-108,720,000
Shares Insiders	0.46%
Shares Institutions	42.96%
Shares Out	5,956,615
Shares Yo Y	1.01%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	ILA 198.9M
Average Volume	17,809.55x
Bv Per Share	87.8
CAPEX	ILA -32.9M
Ch10y	297.6
Ch15y	793.1
Ch1m	-0.43
Ch1w	-4.38
Ch1y	15.92
Ch20y	1,725.4
Ch3m	-2.62
Ch3y	74.88
Ch5y	-20.42
Ch6m	-3.11
Change	0%
Change From Open	0.48
Close	45,800
Days Gap	-0.48
Depreciation Amortization	36,594,000
Dollar Volume	1,123,886,200
Earnings Date	2026-05-19
EBIT	ILA 200.2M
EBITDA	ILA 236.8M
EPS	ILA 20.23
F Score	6
FCF	ILA 202.9M
FCF EV Yield	7.12x
FCF Per Share	ILA 34.06
Financing CF	-177,291,000
Fiscal Year End	December
Founded	1,974
Goodwill	119,508,000
Graham Number	199.91241
Graham Upside	-99.56
Income Tax	ILA 46.7M
Investing CF	-96,299,000
Is Primary Listing	1
Last Earnings Date	2026-03-23
Last Report Date	2025-12-31
Lynch Fair Value	ILA 101
Lynch Upside	-99.78
Ma150	47,137.6
Ma150ch	-2.84%
Ma20	46,947
Ma20ch	-2.44%
Net CF	-37,775,000
Next Earnings Date	2026-05-19
Open	45,580
P FCF Ratio	13.45
P OCF Ratio	11.57
Payment Date	2026-04-20
Position In Range	42.15
Ppne	458,424,000
Price Date	2026-05-08
Price EBITDA	ILA 11.52
Ptbv Ratio	8.1
Relative Volume	1.62x
Revenue	2,904,421,000x
SBC By Revenue	0.14x
Share Based Comp	3,973,000
Tax By Revenue	1.61x
Tax Rate	24.92%
Tr20y	37,290.2%
Tr6m	-0.97%
Volume	24,539
Z Score	4.8

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

TLV/DANE dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+3.4%

$15.6 annual per share

Payout ratio

+69.0%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

-0.1%

2 consecutive years of growth

Total shareholder yield

+2.4%

Next ex-dividend date: 2026-03-30

Performance

TLV/DANE stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TLV/DANE?

Insider, institutional, and short-interest positioning.

Institutional ownership

+43.0%

Share of float held by funds and institutions

Insider ownership

+0.5%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+1.0%

Negative means the company is buying back shares.

Technical

TLV/DANE momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

44.7

Neutral momentum band

Price vs 200-day MA

-3.0%

50/200-day relationship not available

Beta (5Y)

0.00

Less volatile than the market

Sharpe ratio

0.74

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TLV/DANE

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tlv/DANE stock rating?

tlv/DANE is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tlv/DANE analysis?

The full report lives at /stocks/tlv/DANE/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tlv/DANE?

The latest report frames tlv/DANE around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tlv/DANE page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.